Last Posted: Apr 30, 2020
- Association of Rare Pathogenic DNA Variants for Familial Hypercholesterolemia, Hereditary Breast and Ovarian Cancer Syndrome, and Lynch Syndrome With Disease Risk in Adults According to Family History
AP Patel, JAMA Network Open, April 29, 2020 - Skin cancer concerns and genetic risk information-seeking in primary care.
Hay J et al. Public health genomics 2012 15(2) 57-72 - In Different Voices: The Views of People with Disabilities about Return of Results from Precision Medicine Research.
Sabatello Maya et al. Public health genomics 2020 Apr 1-12 - Return of Research-Related Genetic Test Results and Genetic Discrimination Concerns: Facilitators and Barriers of Genetic Research Participation in Diverse Groups.
Burnett-Hartman Andrea N et al. Public health genomics 2020 Apr 1-10 - Genomics knowledge and attitudes among European public health professionals: Results of a cross-sectional survey.
Rosso Annalisa et al. PloS one 2020 15(4) e0230749 - Illustrating Cancer Risk: Patient Risk Communication Preferences and Interest regarding a Novel BRCA1/2 Genetic Risk Modifier Test.
Hamilton Jada G et al. Public health genomics 2020 Mar 1-14 - Research Participants' Attitudes towards Receiving Information on Genetic Susceptibility to Arsenic Toxicity in Rural Bangladesh.
Tamayo Lizeth I et al. Public health genomics 2020 Feb 1-7 - Artificial Intelligence: Power for Civilisation - and for Better Healthcare.
Horgan Denis et al. Public health genomics 2019 Dec 1-17 - Genomic Medicine Year in Review 2019: What’s Hot for Public Health Impact?
MJ Khoury, CDC Blog Post, December 16, 2019 - How to Integrate Personalized Medicine into Prevention? Recommendations from the Personalized Prevention of Chronic Diseases (PRECeDI) Consortium.
Boccia Stefania et al. Public health genomics 2019 Dec 1-7
No hay comentarios:
Publicar un comentario